Rabbit IL-1 beta quantitates rabbit IL-1 beta in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit IL-1 beta.
Rabbit IL-1 beta quantitates rabbit IL-1 beta in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit IL-1 beta.
Rabbit IL-1 beta quantitates rabbit IL-1 beta in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit IL-1 beta.
The beta-interleukin-1 (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. IL-1 beta is synthesized in response to inflammatory stimuli as a 31 kDa inactive proform that accumulates in cytosol. The cleavage of pro-IL-1 beta in the active 17 kDa protein requires the activation of inflammasomas, which are multiprotein complexes that respond to pathogens, stress conditions and other hazard signals. Activation of the inflammasoma triggers the treatment of the precursor of caspase-1 in its active form, which in turn cleaves the pro-IL-1 beta. IL-1 beta does not have a signal sequence peptide for the conventional ER/Golgi pathway and is secreted along the caspase-1 via an alternative mechanism and understood incompletely. Although the beta-IL-1 is most often secreted as active, the secretion of the uncleavened protein can be detectable under certain biological conditions. The signals of the IL-1 beta through two receptors, IL-1RI and IL-1RII, both of which are shared with the IL-1 alpha. The activity of the IL-1 beta may be moderated by the IL-1 receptor antagonist (IL-1RA), a protein produced by many types of cells that blocks receptor binding by competitive inhibition. IL-1 beta plays an important role in defending the innate host by triggering the production of other proinflammatory cytokines in target cells and by triggering acute phase responses to infection and injury. High levels of d的IL-1 beta have been associated with many chronic inflammatory conditions of the beta-IL-1 neutralizing the potential therapeutic value of antibodies.